Review
Open access
Jan 2026
TREM2: A Potential Target for the Targeted Therapy of Metabolic Diseases
This review systematically summarize recent advances in understanding the roles of TREM2 in major metabolic diseases, including atherosclerosis, diabetes mellitus and its complications, obesity, and non‐alcoholic steatohepatitis, while highlighting its functional heterogeneity across different diseases contexts.
Ya-Ling Li, Sheng-Quan Liu, C. Chu et al.
· Mediators of Inflammation · 0 citations